HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert S Hogg Selected Research

Disease Progression

3/2015Costs of health resource utilization among HIV-positive individuals in British Columbia, Canada: results from a population-level study.
8/2014Suboptimal plasma HIV-1 RNA suppression and adherence among sex workers who use illicit drugs in a Canadian setting: an observational cohort study.
1/2014The effect of history of injection drug use and alcoholism on HIV disease progression.
8/2013HIV-1 disease progression during highly active antiretroviral therapy: an application using population-level data in British Columbia: 1996-2011.
12/2010Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level.
1/2007The first ten years: achievements and challenges of the Brazilian program of universal access to HIV/AIDS comprehensive management and care, 1996-2006.
5/2006Aboriginal status is a prognostic factor for mortality among antiretroviral naïve HIV-positive individuals first initiating HAART.
2/2006Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response.
7/2003Rates of disease progression among human immunodeficiency virus-infected persons initiating multiple-drug rescue therapy.
1/2003Influence of polymorphisms within the CX3CR1 and MDR-1 genes on initial antiretroviral therapy response.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert S Hogg Research Topics

Disease

59Acquired Immunodeficiency Syndrome (AIDS)
10/2021 - 07/2002
12HIV Infections (HIV Infection)
08/2010 - 09/2002
11Disease Progression
03/2015 - 12/2002
9Infections
09/2014 - 10/2003
8Hepatitis C
01/2019 - 01/2006
6Substance-Related Disorders (Drug Abuse)
01/2022 - 06/2004
4Coinfection
01/2017 - 02/2006
3HIV Seropositivity
04/2009 - 01/2003
2Viremia
01/2022 - 09/2002
2Drug Overdose
10/2021 - 10/2019
2Erectile Dysfunction
01/2018 - 01/2016
2Neoplasms (Cancer)
01/2017 - 01/2015
2Hypersensitivity (Allergy)
02/2008 - 07/2007
2Hyperlactatemia
03/2004 - 09/2003
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022
1Chronic Disease (Chronic Diseases)
11/2019
1Stroke (Strokes)
09/2019
1Thromboembolism
09/2019
1Schizophrenia (Dementia Praecox)
01/2019
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Chronic Renal Insufficiency
01/2017
1Anus Neoplasms (Anal Cancer)
01/2015
1Drug-Related Side Effects and Adverse Reactions
01/2015
1Alcoholism (Alcohol Abuse)
01/2014
1Condylomata Acuminata (Genital Wart)
08/2012
1Papillomavirus Infections
08/2012
1Hepatitis A (Hepatitis, Infectious)
08/2012
1Malnutrition (Nutritional Deficiencies)
05/2012
1Severe Acute Malnutrition
05/2012
1Mental Disorders (Mental Disorder)
11/2011
1Tuberculosis (Tuberculoses)
09/2011
1Abscess
11/2005
1Opportunistic Infections (Opportunistic Infection)
03/2004
1Alcohol-Related Disorders
12/2003
1Chronic Obstructive Pulmonary Disease (COPD)
04/2003
1Seizures (Absence Seizure)
01/2003
1Lipodystrophy
10/2002
1Wounds and Injuries (Trauma)
05/2002
1Needlestick Injuries (Needlestick Injury)
05/2002

Drug/Important Bio-Agent (IBA)

7RNA (Ribonucleic Acid)IBA
02/2013 - 04/2009
5Heroin (Diamorphine)IBA
10/2019 - 01/2003
5Illicit Drugs (Recreational Drugs)IBA
01/2018 - 01/2003
5Cocaine (Cocaine HCl)IBA
01/2018 - 01/2003
4Methamphetamine (Desoxyn)FDA LinkGeneric
01/2022 - 01/2016
3Protease Inhibitors (Protease Inhibitor)IBA
08/2014 - 02/2005
3VaccinesIBA
09/2013 - 02/2005
3NucleosidesIBA
08/2004 - 09/2003
2Opioid Analgesics (Opioids)IBA
10/2021 - 01/2018
2Viral RNAIBA
01/2015 - 08/2014
2Biomarkers (Surrogate Marker)IBA
06/2014 - 07/2010
2Nevirapine (Viramune)FDA Link
02/2008 - 07/2007
2Anti-HIV Agents (AIDS Drugs)IBA
12/2006 - 01/2006
2Triglycerides (Triacylglycerol)IBA
02/2005 - 08/2002
2Mitochondrial DNA (mtDNA)IBA
03/2004 - 09/2003
2DNA (Deoxyribonucleic Acid)IBA
03/2004 - 09/2003
1Fentanyl (Sublimaze)FDA LinkGeneric
10/2021
1antineoplaston A10 (A 10)IBA
01/2019
1Hallucinogens (Psychedelics)IBA
01/2018
1TabletsIBA
01/2015
1EnzymesIBA
06/2014
1Aspartic Acid (Aspartate)FDA Link
02/2013
1CreatinineIBA
02/2013
1Hemoglobins (Hemoglobin)IBA
02/2013
1Alanine Transaminase (SGPT)IBA
02/2013
1SandIBA
05/2012
1MicronutrientsIBA
05/2012
1Vasodilator Agents (Vasodilators)IBA
03/2007
1NitritesIBA
03/2007
1LipidsIBA
02/2005
1Lipoproteins (Lipoprotein)IBA
02/2005
1Reverse Transcriptase InhibitorsIBA
08/2004
1Peptide Hydrolases (Proteases)FDA Link
08/2004
1ORALIT (ORS)IBA
08/2004
1LopinavirFDA Link
08/2004
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
01/2003
1Chemokine ReceptorsIBA
01/2003
1CholesterolIBA
08/2002
1Stavudine (Zerit)FDA LinkGeneric
08/2002

Therapy/Procedure

45Highly Active Antiretroviral Therapy (HAART)
10/2021 - 07/2002
37Therapeutics
09/2019 - 05/2002
7Art Therapy
11/2017 - 07/2003
1Condoms (Condom)
01/2022
1Operative Surgical Procedures
07/2012
1Aftercare (After-Treatment)
12/2006
1Complementary Therapies (Alternative Medicine)
11/2006
1Length of Stay
04/2003